GPR
G protein-coupled receptors (GPCRs) comprise the largest family of cell surface receptors in the human genome, regulating a plethora of physiological responses and serving as frequent drug targets. Four main groups of GPCRs are recognized and classified according to their pharmacological properties: Class A is rhodopsin-like; Class B is secretin-like; Class C is comprised of metabotropic glutamate/pheromone; and Class D is comprised of frizzled receptors. While GPCRs regulate many aspects of tumorigenesis as well as many cancer-associated signaling pathways, only a few drugs aiming to inhibit GPCRs are currently used in cancer, these signal proteins are PARs, chemokine receptors, Gα12/13 proteins, lysophosphatidic acid (LPA), and GPCR-mediated pathways such as the WNT and Hippo signaling pathways.
References
1. Bar-Shavit R, et al. Int J Mol Sci. 2016;17(8):1320.
References
1. Bar-Shavit R, et al. Int J Mol Sci. 2016;17(8):1320.
Cell Cycle/DNA Damage
ABC(8)
AChR(5)
Antifolate(9)
ATM/ATR(23)
Aurora Kinase(38)
CLK(15)
c-Myc(16)
DHFR(4)
DNA Alkylator(30)
DNA gyrase(8)
DNA Repair Protein(21)
DNA/RNA Synthesis(94)
DNA-PK(11)
GPR(29)
HDAC(117)
Hec1/Nek2(9)
Integrin(41)
LIM Kinase (LIMK)(5)
Mps1/TTK(1)
Nucleoside Antimetabolite/Analog(25)
Other Targets(2)
PAK(7)
PARP(32)
PLK(11)
Potassium Channel(67)
RAD51(1)
Rho(6)
ROCK(16)
Telomerase(6)
Topoisomerase(46)
Wee1(2)